Treating pediatric migraine: An expert opinion

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 7, 2012, Pages 959-966

  O'Brien, Hope L ^a,b   Kabbouche, Marielle A ^a,b   Hershey, Andrew D ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acute headache treatment; Non pharmacological treatment; Nutraceuticals in pediatrics; Pediatric headache; Pediatric migraine; Prophylactic headache treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; AMITRIPTYLINE; BOTULINUM TOXIN A; CLONIDINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; ELETRIPTAN; ETIRACETAM; FLUNARIZINE; FROVATRIPTAN; GABAPENTIN; IBUPROFEN; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NIMODIPINE; NORTRIPTYLINE; PARACETAMOL; PREGABALIN; PROCHLORPERAZINE; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZOLMITRIPTAN; ZONISAMIDE;

ABDOMINAL PAIN; ANXIETY; APPETITE; ASTHENIA; BEDTIME DOSAGE; BEHAVIOR THERAPY; BODY WEIGHT; CHEMOPROPHYLAXIS; CHEWABLE TABLET; CHILD; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG MEGADOSE; DRY EYE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HEADACHE; HUMAN; HYPOTENSION; LIVER DYSFUNCTION; LOW DRUG DOSE; MIGRAINE; NAUSEA; NEPHROLITHIASIS; PANCREATITIS; PARESTHESIA; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SUICIDE; SWEATING; TREMOR; WEIGHT REDUCTION; XEROSTOMIA;

ACETAMINOPHEN; ANALGESICS; BEHAVIOR THERAPY; CHILD; HUMANS; IBUPROFEN; MIGRAINE DISORDERS;

EID: 84860122976     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.677434     Document Type: Review

References (54)

1. Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 2010;52(12):1088-97
2. Lewis DW, Kellsein D, Sahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002;42(8):780-6 (Pubitemid 35291512)
3. Hamalainen ML, Hoppu K, Valkeila E, Santvuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 1997;48:103-7
4. Lipton RB, Goldstein J, Baggish JS, et al. Aspirin is efficacious for the treatment of acute migraine. Headache 2005;45:283-92 (Pubitemid 40530192)
5. Lewis DW, Ashwal S, Hershey A, et al. Practice Parameter: pharmacological treatment of migraine headache in children and adolescents. Neurology 2004;63:2215-24
6. Available from: http://www.healthcentral. com/migraine/c/202/73741/axert- adolescents [Accessed 1 November 2009]
7. Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008;48:1326-36
8. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000;106:989-97
9. Rothner AD, Winner P, Nett R, et al. Long-term tolerability of sumatriptan nasal spray for adolescent migraine: results of an open-label study. Clin Ther 2001;22:1533-46
10. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999;52(7):1507-10 (Pubitemid 29190554)
11. Winner P, Rothner D, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000;106:989-97
12. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 2004;62(6):883-7 (Pubitemid 38435772)
13. Winner P, Lewis D, Visser H, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 2002;42:49-55 (Pubitemid 34136611)
14. Visser WH, Winner P, Strohmaier K, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two-open-label, multiple-attack studies. Headache 2004;44(9):891-9 (Pubitemid 39362313)
15. Ahonen K, Hamalainen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology 2006;67(7):1135-40 (Pubitemid 44563817)
16. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract 2000;54(7):466-9
17. Lewis DW, Winner P, Hershey AD, Wasiewski WW. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120:390-6 (Pubitemid 47219510)
18. Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. J Headache Pain 2006;7(2)95-7 (Pubitemid 44419862)
19. Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008;48(9):1326-36
20. Rothner A. Efficacy and safety of naratriptan tablets in adolescent migraine [abstract]. J Neurol Sci 1997;150:S106
21. Sallucci C. Naratriptan vs. ibuprofen in acute migraine treatment in children. [abstract]. Cephalalgia 2000;20:287
22. Winner P, Linder SL, Lipton RB, et al. Eletriptan for the acute treatment of migraine in adolescents; results of a double-blind, placebo-controlled trial. Headache 2007;47:511-18 (Pubitemid 46625260)
23. Diener HC, Jansen JP, Reches A, et al. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomized, double-blind, placebo-controlled comparison. Eur Neurol 2002;47:99-107 (Pubitemid 34161162)
24. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007;297(13):1443-54 (Pubitemid 46556470)
25. Mannix LK, Martin VT, Diamond ML, et al. Combination treatment for menstrual migraine and dysmenorrheal using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol 2009;114(1):106-13
26. McDonald SA, Hershey AD, Pearlman E, et al. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache 2011;9:1374-87
27. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004;43:256-62 (Pubitemid 38141471)
28. Larkin G. Intravenous ketorolac vs. intravenous prochlorperazine for the treatment of migraine headache. Acad Emerg Med 1999;6:668-70 (Pubitemid 29275246)
29. Rothner MA, Powers SW, Hershey AD, et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache 2009;49:106-9
30. Linder SL. Treatment of acute childhood migraine headache with dihydroergotamine mesylate. Headache 1994;34:578-80 (Pubitemid 24378707)
31. Levinstein B. A comparative study of cyproheptadine, amitriptyline and propranolol in the treatment of adolescent migraine. Cephalalgia 1991;11:122-12
32. Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache 1977;17:61-3 (Pubitemid 8111147)
33. Caruso JM, Brown WD Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000;40:672-6
34. Serdaroglu G, Erhan E, Tekgul H, et al. Sodium valproate prophylaxis in childhood migraine. Headache 2002;42:819-22 (Pubitemid 35291518)
35. Apostol G, Cady R, Laforet G, et al. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache 2008;48:1012-25 (Pubitemid 351952078)
36. Apostol G, Pakalnis A, Laforet G, et al. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents. Headache 2009;49:36-44
37. Hershey AD, Powers SW, Vockell AL, et al. Effectiveness of topiramate in the prevention of childhood headaches. Headache 2002;42(8):810-18 (Pubitemid 35291517)
38. Winner P, Pearlman E, Linder S, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trail. Headache 2005;45:1304-12 (Pubitemid 350004943)
39. Unalp A, Uran N, Ozturk A. Comparison of effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol 2008;23:1377-81
40. Forsythe WI, Gillies D, Sills MA. Propranolol ('Inderal') in the treatment of childhood migraine. Dev Med Child Neurol 1984;26:737-41 (Pubitemid 15175452)
41. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987;79:593-7 (Pubitemid 17051427)
42. Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F. Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur J Paediatr Neurol 2005;9:333-8 (Pubitemid 41700816)
43. Sills M, Congdon P, Forsythe I. Clonidine and childhood migraine: a pilot and double-blind study. Dev Med Child Neurol 1982;24:837-41 (Pubitemid 13250732)
44. Sorge F, De Simone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988;8:1-6 (Pubitemid 18091138)
45. Battistella PA, Ruffilli R, Moro R, et al. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 1990;30:267-8
46. Ahmed K, Oas K, Mack KJ, Garza I. Experience with Botulinum toxin type a in medically intractable pediatric chronic daily headache. Pediatr Neurol 2010;43(5):316-19
47. Bruijn J, Duivenvoorden H, Passchier J, et al. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomized, double-blind, cross-over trial. Cephalalgia 2010;30(12):1426-34
48. Condo M, Posar A, Arbizzania A, Parmegggiani A. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain 2009;10:361-5
49. Maizels M, Blumerfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 2004;44(9):885-90 (Pubitemid 39362312)
50. Hershey AD, Powers SW, Vockell AL, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007;47:73-80 (Pubitemid 46096060)
51. Slater SK, Nelson TD, Kabbouche MA, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2001(8):897-905
52. Oelkers Ax R, Leins A, Parzer P, et al. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain 2008;12:301-13 (Pubitemid 351241190)
53. Wang F, Van Den Eeden SK, Ackerson L, et al. Oral magnesium oxide prophylaxis of frequent migrainosus headache in children: a randomized, double-blind, placebo-controlled trail. Headache 2003;43:601-10 (Pubitemid 36828795)
54. Trautmann E, Kroner-Herwig B. A randomized controlled trial of Internet-based self-help training for recurrent headache in childhood and adolescence. Behav Res Ther 2010;48:28-37